On June 5, 2024, Michael J. Fox was appointed to the board of directors and the Compensation Committee of the Board of Cue Biopharma, Inc., following the recommendation of the Corporate Governance and Nominating Committee of the Board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9402 USD | -0.85% |
|
-2.06% | -64.39% |
Jul. 01 | Cue Biopharma, Inc.(NasdaqCM:CUE) dropped from Russell 3000E Growth Index | CI |
Jul. 01 | Cue Biopharma, Inc.(NasdaqCM:CUE) dropped from Russell 2000 Growth Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-64.39% | 45.73M | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- CUE Stock
- News Cue Biopharma, Inc.
- Cue Biopharma, Inc. Appoints Michael J. Fox to the Board of Directors and the Compensation Committee